H|T: The Healthtech Times – Ozempic maker Novo Nordisk buys Montréal's Inversago for $1 billion

The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.

Related Keywords

New York ,United States ,Toronto ,Ontario ,Canada ,Pinegrove ,Texas ,Denmark ,Brookfield ,Nova Scotia ,Canadian ,American ,Danish ,Elon Musk ,Inversago Pharma ,Mark Warner ,James Connolly ,Sundar Pichai ,Shambhavi Mishra ,Alex Riehl ,Texas Workforce Commission On ,The Globe And Mail ,Microsoft ,Carleton University ,Reuters ,Babylon Health ,Peter Thiel Founders Fund ,Google ,Twitter ,Government Of Canada Future Skills Centre ,Brookfield Asset Management ,Thiel Founders Fund ,Novo Nordisk ,Toronto Metropolitan University Diversity Institute ,Healthtech Times ,Silicon Valley ,Sequoia Heritage ,Financial Times ,Pinegrove Capital ,Advanced Digital ,Professional Training ,Future Skills Centre ,Toronto Metropolitan University ,Diversity Institute ,North American ,Founders Fund ,Peter Thiel ,After Rescue Merger Falls Apart ,Texas Workforce Commission ,Wall Street ,Capital Whisperer Sue Umapathy ,Sue Umapathy ,Capital Whisperer ,United State ,Omers Ventures ,Sequoia Holdings ,Pinegrove Capital Partners ,Antler ,Trbcx ,Ozempic ,Neuralink ,Babylon ,Doximity ,Amazon ,Maven Clinic ,Hims Amp Hers ,Voxneuro ,Med Palm 2 ,Healthtech ,